Analistic

Friday 20 March 2015

Retin A Micro Gel TRETINOIN MICROSPHERES


Retina-A Micro (tretinoin) is a topical acne agent. It is used for treating acne vulgaris, smoothening of fine wrinkles, and fading hyper-pigmentation of aged skin. The most common side effects are peeling, excessive dry skin, burning, stinging, erythema, and pruritus. Photosensitivity also occurs. Therefore, sunlight exposure should be minimized while using Retin-A Micro.
Apply small (pea-sized) amount of Retin-A Micro to affected areas nightly after washing skin. Avoid applying to lips, mucous membranes, and close to eyes. Other topical medications that cause peeling or drying should not be combined with Retin-A. Examples include medicated or abrasive soaps and cleansers, and products containing alcohol, astringents, benzoyl peroxide, sulfur, resorcinol, or salicylic acid. Some reports suggests that Retin-A may be associated with birth defects but a definite causal relationship has not been established.
Our Retin-A (tretinoin) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

Friday 6 March 2015

Oxycodone Percocet Acetaminophen tablets


Oxycodone is a semisynthetic opioid synthesized from thebaine, an opioid alkaloid found in the Persian poppy and one of the many opioid alkaloids found in the opium poppy. It is an analgesic generally indicated for relief of moderate to severe pain. It was developed in 1917 in Germany as one of several new semi-synthetic opioids in an attempt to improve on the existing opioids.
Oxycodone is available as single-ingredient medication in immediate release and controlled release. Parenteral formulations of 10 mg/mL and 50mg/mL are available in the U.K. for IV/IM administration. Combination products formulated with non-narcotic ingredients such as nonsteroidal anti-inflammatory drugs (NSAID) and paracetamol (acetaminophen) are also available as immediate release formulations; a combination with naloxone is available in managed-release tablets, naloxone which precipitates opioid withdrawal if the tablet is tampered with.